Discrepancy between cell injury and benzodiazepine receptor binding after transient middle cerebral artery occlusion in rats

Synapse

Volumn 53, Issue 4, 2004, Pages 234-239

  Abe, Kohji ^a,b   Kashiwagi, Yuto ^a   Tokumura, Miwa ^b   Hosoi, Rie ^a   Hatazawa, Jun ^c   Inoue, Osamu ^a  

^a OSAKA UNIVERSITY   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoradiography; Benzodiazepine receptor; Dopamine D1 receptor; Infarction; Middle cerebral artery occlusion; Muscarinic acetylcholine receptor; Rats

Indexed keywords

1 METHYL 4 PIPERIDYL BENZILATE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR; DOPAMINE 1 RECEPTOR; FLUMAZENIL; MUSCARINIC RECEPTOR;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PERFUSION; CELL DAMAGE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; AUTORADIOGRAPHY; BENZILATES; BINDING SITES; BINDING, COMPETITIVE; CEREBRAL CORTEX; CEREBRAL INFARCTION; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FLUMAZENIL; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NERVE DEGENERATION; PIPERIDINES; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, DOPAMINE D1; RECEPTORS, GABA-A; RECEPTORS, MUSCARINIC; REPERFUSION INJURY; SENSITIVITY AND SPECIFICITY; TRITIUM;

EID: 3843059189     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20057     Document Type: Article

References (31)

1. Araki T, Kato H, Shuto K, Fujiwara T, Kogure K, Itoyama Y. 1996. Effects of cerebral ischemia on dopamine receptors in the gerbil striatum. Eur J Pharmacol 306:73-79.
2. Baron JC. 2001. Mapping the ischaemic penumbra with PET: a new approach. Brain 124:2-4.
3. Bryan RN, Levy LM, Whitlow WD, Killian JM, Preziosi TJ, Rosario JA. 1991. Diagnosis of acute cerebral infarction: comparison of CT and MR imaging. AJNR Am J Neuroradiol 12:611-620.
4. Chang CJ, Ishii H, Yamamoto H, Yamamoto T, Spatz M. 1993. Effects of cerebral ischemia on regional dopamine release and D1 and D2 receptors. J Neurochem 60:1483-1490.
5. Coyle JT, Puttfarcken P. 1993. Oxidative stress, glutamate and neurodegenerative disorders. Science 262:689-695.
6. Dawson DA, Robinson MJ, Macrae IM, Reid JL, McCulloch J. 1992. Autoradiographic evaluation of forskolin and D1 dopamine receptor binding in a rat model of focal cerebral ischaemia. Brain Res 577: 210-217.
7. Filloux F, Townsend JJ. 1993. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp Nerol 119:79-88.
8. Filloux F, Dawson TM, Wamsley JK. 1988. Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase. Brain Res Bull 20:447-459.
9. Fiorelli M, Toni D, Bastianello S, Sacchetti ML, Sette G, Falcou A, Argentine C, Lorenzano S, Di Angelantonio E, Bozzao L. 2000. Computed tomography findings in the first few hours of ischemic stroke: implications for the clinician. J Neurol Sci 173:10-17.
10. Heiss WD. 2001. Imaging the ischemic penumbra and treatment effects by PET. Keio J Med 50:249-256.
11. Heiss WD, Graf R, Fujita T, et al. 1997. Early detection of irreversibly damaged ischemic tissue by flumazenil positron emission tomography in cats. Stroke 28:2045-2051.
12. 11C]flumazenil/H2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke 31:366-369.
13. 3H-QNB in mouse brain. J Neural Transm 106:583-592.
14. Inoue O, Kobayashi K, Gee A. 1999. Changes in apparent rates of receptor binding in the intact brain in relation to the heterogeneity of reaction environments. Grit Rev Neurobiol 13:199-225.
15. Inoue O, Yanamoto K, Fujiwara Y, Hosoi R, Kobayashi K, Tsukada H. 2003. Sensitivities of benzodiazepine receptor binding and muscarinic acetylcholine receptor binding for the detection of neural cell death caused by sodium nitroprusside microinjection in rat brain. Synapse 49:134-141.
16. Matsuda H, Tsuji S, Kuji I, Shiba K, Hisada K, Mori H. 1995. Dual tracer autoradiography using 125I-iomazenil and 99Tcm-HMPAO in experimental brain ischaemia. Nucl Med Commun 16:581-590.
17. Menotti A, Jacobs Jr DR, Blackburn H, Kromhout D, Nissinen A, Nedeljkovic S, Buzina R, Mohacek I, Seccareccia F, Giampaoli S, Dontas A, Aravanis C, Toshima H. 1996. Twenty-five-year prediction of stroke deaths in the seven countries study: the role of blood pressure and its changes. Stroke 27:381-387.
18. 11C]NMPB), a muscarinic acetylcholine receptor antagonist. Nucl Med Biol 22:13-17.
19. Nagasawa H, Araki T, Kogure K. 1992. Alteration of dopamine D1 receptor in the strionigral system of the postischemic rat brain. Neurosci Lett 134:271-274.
20. 11C]methyl-4- piperidyl benzilate in the conscious monkey brain. Nucl Med Biol 27:733-740.
21. Odano I, Miyashita K, Minoshima S, Nakajima T, Fujita M, Takahashi N, Ikuta F. 1995. A potential use of a 123I-labelled benzodiazepine receptor antagonist as a predictor of neuronal cell viability: comparisons with 14C-labelled 2-deoxyglucose autoradiography and histopathological examination. Nucl Med Commun 16:443-446.
22. O'Neill M, Canney M, Barley B, Junien JL, Leonard BE. 1996. The novel sigma ligand JO 1994 protects against ischaemia-induced behavioural changes, cell death and receptor dysfunction in the gerbil. Neurochem Int 28:193-207.
23. Ouchi Y, Tsukada H, Kakiuchi T, Nishiyama S, Futatsubashi M. 1998. Changes in cerebral blood flow and postsynaptic muscarinic cholinergic activity in rats with bilateral carotid artery ligation. J Nucl Med 39:198-202.
24. Phebus LA, Clements JA. 1989. Effects of transient, global, cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolites. Life Sci 44:1335-1342.
25. Ryu JH, Yanai K, Iwata R, Ido T, Watanabe T. 1994. Heterogeneous distributions of histamine H3, dopamine D1 and D2 receptors in rat brain. Neuroreport 5:621-624.
26. Sakamoto A, Ohnishi ST, Ohnishi T, Ogawa R. 1991. Relationship between free radical production and lipid peroxidation during ischemia-reperfusion injury in the rat brain. Brain Res 554:186-192.
27. Sette G, Baron JC, Young AR, Miyazawa H, Tillet I, Barré L, Travere JM, Derlon JM, MacKenzie ET. 1993. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in anesthetized baboon. Stroke 24:2046-2057.
28. Siesjö BK. 1992. Pathophysiology and treatment of focal cerebral ischaemia. 1. Pathophysiology. J Neurosurg 77:169-184.
29. Tuomilehto J, Rastenyte D, Sivenius J, Sarti C, Immonen-Raiha P, Kaarsalo E, Kuulasmaa K, Narva EV, Salomaa V, Salmi K, Torppa J. 1996. Ten-year trends in stroke incidence and mortality in the FINMONICA Stroke Study. Stroke 27:825-832.
30. Warach S, Boska M, Welch KM. 1997. Pitfalls and potential of clinical diffusion-weighted MR imaging in acute stroke [Editorial]. Stroke 28:481-482.
31. Yanamoto K, Hosoi R, Uesaka Y, Abe K, Tsukada H, Inoue O. 2003. Intrastriatal microinjection of sodium nitroprusside induces cell death and reduces binding of dopaminergic receptors. Synapse 50: 137-143.